However, it has been reported that EPO exacerbates cerebral oedema, BBB leakage, and extracellular matrix breakdown in thrombolysed mice [36], suggesting that ischemic stroke patients may be potential candidates for rhEPO treatment, when not suitable for thrombolysis [35]. Here, EPO is linked to ischemic stroke.